Rexahn Pharmaceuticals (RNN +3.3%) moves up this morning after being initiated by analysts at...

|About: Rexahn Pharmaceuticals Inc (RNN)|By:, SA News Editor

Rexahn Pharmaceuticals (RNN +3.3%) moves up this morning after being initiated by analysts at Maxim with a Buy and a price target of $1.50 a share. The company specializes in oncology and CNS therapeutics, and has recently expanded its intellectual property around isoquinolinamine, a class of potent anti-cancer compounds, which provide potent anti-tumor activities in several human cancer cell lines, such as breast, prostate, colon, ovary, kidney, pancreas, glioblastoma and melanoma.